Induction of Activating Transcription Factor 3 Is Associated with Cisplatin Responsiveness in Non–Small Cell Lung Carcinoma Cells

Induction of Activating Transcription Factor 3 Is Associated with Cisplatin Responsiveness in Non–Small Cell Lung Carcinoma Cells

Non–small cell lung carcinoma (NSCLC) is the most common cause of cancer deaths, with platin-based combination chemotherapy the most efficacious therapies. Gains in overall survival are modest, highlighting the need for novel therapeutic approaches including the development of next-generation platin...

Full description

Bibliographic Details
Main Authors: Jair Bar, Mohamed S. Hasim, Tabassom Baghai, Nima Niknejad, Theodore J. Perkins, David J. Stewart, Harmanjatinder S. Sekhon, Patrick J. Villeneuve, Jim Dimitroulakos
Format: Article
Language:English
Published: Elsevier 2016-09-01
Series:Neoplasia: An International Journal for Oncology Research
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558616301129

Internet

http://www.sciencedirect.com/science/article/pii/S1476558616301129

Similar Items